CD226 and neoplasm: We next assessed the NSCLC tumor biopsy from patient 006 for expression of the cognate ligands for NKGD2 (i.e., MICA/B), DNAM-1 (i.e., CD112), and NKp30 (i.e., B7H6 and BAG6).